phase readout
saveNCT03837184: Single-Dose Gene Replacement Therapy Using for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: Novartis Gene Therapies. Phase: PHASE3. Conditions: Spinal Muscular Atrophy Type I
view source ↗
comments(0)
5-min edit window · permanent after that